Cargando…
Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topolo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410174/ https://www.ncbi.nlm.nih.gov/pubmed/30795556 http://dx.doi.org/10.3390/pharmaceutics11020091 |
_version_ | 1783402179616309248 |
---|---|
author | Knauer, Nadezhda Pashkina, Ekaterina Apartsin, Evgeny |
author_facet | Knauer, Nadezhda Pashkina, Ekaterina Apartsin, Evgeny |
author_sort | Knauer, Nadezhda |
collection | PubMed |
description | Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topology of formulation components can drastically change their activity. This is why the supramolecular topology of therapeutic nanoconstructions has to be considered. Herein, we discuss several topological groups used for the design of nanoformulations for peptide and protein delivery: modification of polypeptide chains by host-guest interactions; packaging of proteins and peptides into liposomes; complexation and conjugation with dendrimers. Each topological type has its own advantages and disadvantages, so careful design of nanoformulations is needed. Ideally, each case where nanomedicine is needed requires a therapeutic construction specially created for that taking into account features of the administration route, target tissue, or organ, properties of a drug, its bioavailability, etc. The wide number of studies in the field of protein delivery by supramolecular and nanocarriers for proteins and peptides evidence their increasing potential for different aspects of the innovative medicine. Although significant progress has been achieved in the field, there are several remaining challenges to be overcome in future. |
format | Online Article Text |
id | pubmed-6410174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64101742019-03-29 Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins Knauer, Nadezhda Pashkina, Ekaterina Apartsin, Evgeny Pharmaceutics Review Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topology of formulation components can drastically change their activity. This is why the supramolecular topology of therapeutic nanoconstructions has to be considered. Herein, we discuss several topological groups used for the design of nanoformulations for peptide and protein delivery: modification of polypeptide chains by host-guest interactions; packaging of proteins and peptides into liposomes; complexation and conjugation with dendrimers. Each topological type has its own advantages and disadvantages, so careful design of nanoformulations is needed. Ideally, each case where nanomedicine is needed requires a therapeutic construction specially created for that taking into account features of the administration route, target tissue, or organ, properties of a drug, its bioavailability, etc. The wide number of studies in the field of protein delivery by supramolecular and nanocarriers for proteins and peptides evidence their increasing potential for different aspects of the innovative medicine. Although significant progress has been achieved in the field, there are several remaining challenges to be overcome in future. MDPI 2019-02-21 /pmc/articles/PMC6410174/ /pubmed/30795556 http://dx.doi.org/10.3390/pharmaceutics11020091 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Knauer, Nadezhda Pashkina, Ekaterina Apartsin, Evgeny Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title | Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title_full | Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title_fullStr | Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title_full_unstemmed | Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title_short | Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins |
title_sort | topological aspects of the design of nanocarriers for therapeutic peptides and proteins |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410174/ https://www.ncbi.nlm.nih.gov/pubmed/30795556 http://dx.doi.org/10.3390/pharmaceutics11020091 |
work_keys_str_mv | AT knauernadezhda topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins AT pashkinaekaterina topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins AT apartsinevgeny topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins |